Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × tocilizumab × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 9 Lymphoma, Non-Hodgkin 6 Melanoma 3 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Recurrence 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Craniopharyngioma 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Nasopharyngeal Neoplasms 1 Mesothelioma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Immune-related Adverse Events 1 Hematologic Neoplasms 1 Esophageal Neoplasms 1 Cytokine Release Syndrome 1 Carcinoma, Transitional Cell 1 Carcinoma, Merkel Cell 1

Interventions

Bevacizumab 24 atezolizumab 19 durvalumab 18 Specimen Handling 15 pembrolizumab 12 lenvatinib 11 Magnetic Resonance Spectroscopy 11 tremelimumab 10 Nivolumab 10 Sorafenib 8 Radiosurgery 8 Cyclophosphamide 6 camrelizumab 5 apatinib 5 Ipilimumab 5 tislelizumab 4 regorafenib 4 fludarabine 4 cabozantinib 4 X-Rays 4 Immunoglobulin G 4 sintilimab 3 gadolinium ethoxybenzyl DTPA 3 Immune Checkpoint Inhibitors 3 Ethiodized Oil 3 E-7386 3 Disulfides 3 Blood Specimen Collection 3 Biopsy 3 gadobutrol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡